Latest News
Copy of MergerAnncouncementPost
New U.S. corporation consolidates chronic and infectious disease vaccines and immunotherapeutics to democratize health on a global scale DALLAS, TX  (April 1, 2021) – COVAXX and United Neuroscience today announced the consolidation of their vaccine development efforts under the newly formed holding company, Vaxxinity, Inc. The U.S. corporation is based in Dallas, Texas, with operations in Asia, Europe, Latin America, and the United States. COVAXX and United Neuroscience are now wholly-owned subsidiaries of Vaxxinity. Lou Reese, Executive chairman of COVAXX, has been appointed Executive Chairman of Vaxxinity. Mei Mei Hu, CEO of COVAXX, has been appointed CEO of Vaxxinity.
Media Contacts

Have a media inquiry? Looking for more info ?

Contact one of our team members below:

Diane Murphy

Media Relations

[email protected]

Subscribe to Newsletter